TRAM2 and hepatocellular carcinoma: Moreover, we used actinomycin D (ACT-d) to inhibit transcription in Huh-7 and HCC-LM3 cell lines transduced with sh-NC and sh-RBM15B-3 and measured the relative changes in TRAM2 mRNA levels over time (Figure 5F).